https://www.selleckchem.com/products/S31-201.html
After minimum 3-year follow-up, 298 (81%) could be managed on low-dose valproate ( less then 1,000 mg) without any relapse during 12 to 80 months follow-up. Conclusion Significant number of patients with IGE can be managed on low-dose valproate with good seizure control and less side effects.Objectives In patients with neurocysticercosis (NCC), an accurate risk prediction would allow a better therapeutic approach; however, there are currently no tools that can enhance the accuracy of risk prediction. We designed a prognostic scoring s
Like
Comment
Share
